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Postoperative surgical site infections remain a major
source of illness and a less frequent cause of death in the
surgical patient (1). These infections number approximately
500,000 per year, among an estimated 27 million surgical
procedures (2), and account for approximately one quarter of
the estimated 2 million nosocomial infections in the United
States each year (3). Infections result in longer hospitaliza-
tion and higher costs.
The incidence of infection varies from surgeon to surgeon,
from hospital to hospital, from one surgical procedure to
another, and—most importantly—from one patient to
another. During the mid1970s, the average hospital stay
doubled, and the cost of hospitalization was correspondingly
increased when postoperative infection developed after six
common operations (4). These costs and the length of hospital
stay are undoubtedly lower today for most surgical procedures
that are done on an outpatient basis, such as laparoscopic
(minimally invasive) operations or those that require only a
short postoperative stay. In these cases, most infections are
diagnosed and treated in the outpatient clinic or the patient’s
home. However, major complications such as deep sternal
infections continue to have a grave impact, increasing the
duration of hospitalization as much as 20-fold and the cost of
hospitalization fivefold (5). Any surgical site infection after
open heart surgery results in a substantial net loss of
reimbursement to the hospital compared with uninfected
cases, a factor that should motivate hospitals to minimize the
incidence of postoperative infections (6).
Description of Surgical Site Infections
The Centers for Disease Control and Prevention (CDC)
term for infections associated with surgical procedures was
changed from surgical wound infection to surgical site
infection in 1992 (7). These infections are classified into
incisional, organ, or other organs and spaces manipulated
during an operation; incisional infections are further divided
into superficial (skin and subcutaneous tissue) and deep (deep
soft tissue-muscle and fascia). Detailed criteria for these
definitions have been described (7). These definitions should
be followed universally for surveillance, prevention, and
control of surgical site infections.
Microbiology of Surgical Site Infections
The pathogens isolated from infections differ, primarily
depending on the type of surgical procedure. In clean surgical
procedures, in which the gastrointestinal, gynecologic, and
respiratory tracts have not been entered, Staphylococcus
aureus from the exogenous environment or the patient’s skin
flora is the usual cause of infection. In other categories of
surgical procedures, including clean-contaminated, contami-
nated, and dirty, the polymicrobial aerobic and anaerobic
flora closely resembling the normal endogenous microflora of
the surgically resected organ are the most frequently isolated
pathogens (8).
According to data from the National Nosocomial
Infections Surveillance System (NNIS), there has been little
change in the incidence and distribution of the pathogens
isolated from infections during the last decade (9). However,
more of these pathogens show antimicrobial-drug resistance,
especially methicillin-resistant S. aureus (10). Postoperative
infections, including surgical site infections, were caused by
multiple organisms in a multicenter outbreak due to
contamination of an intravenous anesthetic, propofol (11). In
this outbreak, CDC identified 62 patients at seven hospitals
who had postoperative infections, primarily of the
bloodstream or surgical site, after exposure to propofol. Only
exposure to this anesthetic was substantially associated with
these postoperative infections. In six of the seven hospitals,
the same pathogen was isolated from several infected
patients. The infections were due to extrinsic contamination
of the propofol by the anesthesia personnel, who frequently
carried the pathogens in lesions on their hands or scalp or in
their nares. Lapses in aseptic technique and reuse of single-
use vials for several patients were important factors in these
outbreaks (11,12). This report stresses the importance of
conducting a formal epidemiologic investigation when a
cluster of infections involves an unusual organism such as
Moraxella osloensis or Serratia marcescens.
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Prevention of Surgical Site Infections
The most critical factors in the prevention of
postoperative infections, although difficult to quantify, are
the sound judgment and proper technique of the surgeon and
surgical team, as well as the general health and disease state
of the patient (13-14). Other factors influence the
development of postoperative wound infection, especially in
clean surgical procedures, for which the infection rate (<3%) is
generally low. Infections in these patients may be due solely
to airborne exogenous microorganisms (15).
In 1999, CDC’s Health Care Infection Control Practices
Advisory Committee published revised guidelines for the
prevention of infections (Table 1). This guideline delves
extensively into the literature concerning perioperative
factors associated with postoperative infections (16). The
1999 edition of the guideline has been extensively revised
(Table 2).
Prophylactic Antibiotic Use in the Surgical Patient
The use of antibiotic prophylaxis before surgery has
evolved greatly in the last 20 years (17). Improvements in the
timing of initial administration, the appropriate choice of
antibiotic agents, and shorter durations of administration
have defined more clearly the value of this technique in
reducing postoperative wound infections. Some historical
milestones of the last 4 decades shed light on the current
situation.
Historical Aspects
Confusing and heated debate concerning the efficacy of
prophylactic antibiotics in surgery followed the publication of
clinical trials during the 1950s. Errors in study design of
these early efforts included nonrandomization, lack of
blinding, faulty timing of initial antibiotic administration,
prolonged antibiotic use, incorrect choices of antimicrobial
agents, and inappropriate choices of control agents.
Experimental studies published during the early 1960s
helped clarify many of these problems and resulted in a more
scientifically accurate approach to antimicrobial prophylaxis.
Most important was the report by Burke (18), which
demonstrated the crucial relationship between timing of
antibiotic administration and its prophylactic efficacy. His
experimental studies showed that to greatly reduce
experimental skin infection produced by penicillin-sensitive
S. aureus, the penicillin had to be in the skin shortly before or
at the time of bacterial exposure. This study and others
fostered the attitude that to prevent subsequent infection the
antibiotic must be in the tissues before or at the time of
bacterial contamination. This important change in strategy
helped correct the common error of first administering the
prophylactic antibiotic in the recovery room.
As early as 1964, Bernard and Cole (19) reported on the
successful use of prophylactic antibiotics in a randomized,
prospective, placebo-controlled clinical study of abdominal
operations on the gastrointestinal tract. The success of
antibiotic prophylaxis noted in this early study was clearly
due to the authors’ appropriate patient selection and wise
choice of available agents, as well as the timing of
administration. Further advances in understanding of
antibiotic prophylaxis in abdominal surgery occurred in the
1970s. During this decade, the qualitative and quantitative
nature of the endogenous gastrointestinal flora in health and
disease was appropriately defined (20). Many prospective,
blinded clinical studies in the 1980s and 1990s prompted
Table 1. Hospital Infection Control Practices Advisory Committee partial recommendations for the prevention of surgical site infection,1999 (16)
Rankings
Category 1A Strongly recommended for implementation and supported by well-designed experimental, clinical, or epidemiologic
studies
Category 1B Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies
and strong theoretical rationale
Category II Suggested for implementation and supported by suggestive clinical or epidemiologic studies or theoretical rationale
No recommendation; Practices for which insufficient evidence or no consensus regarding efficacy exists
  unresolved issue.
Recommendations—Preoperative—partial and modified
A. Preparation of the patient
Category 1A Treat remote infection before elective operation; postpone surgery until treated; Do not remove hair from operative
site unless necessary to facilitate surgery; If hair is removed, do immediately before surgery, preferably with electric
clippers
Category 1B Control serum blood glucose perioperatively; Cessation of tobacco use 30 days before surgery; Do not withhold
necessary blood products to prevent SSIs; Shower or bath on night before operative procedure; Wash incision site
before performing antiseptic skin preparation with approved agent
Category II Prepare skin in concentric circles from incision site; Keep preoperative stay in hospital as short as possible
Unresolved Improve nutritional status; Use of mupirocin in nares; Improve oxygenation of wound space; Taper or discontinue
systemic steroid use before elective surgery
B. Antimicrobial prophylaxis
Category 1A Select (if indicated) an antimicrobial agent with efficacy against expected pathogen; Intravenous route used to
ascertain adequate serum levels during operation and for at most a few hours after incision closed; Before elective
colorectal operations, in addition to parenteral agent, mechanically prepare the colon by use of enemas and
cathartics.  Administer nonabsorbable oral antimicrobial agents in divided doses on the day before the operation
Category 1B Do not routinely use vancomycin for antimicrobial prophylaxis
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Table 2. Changes in CDC surgical site infections prevention guidelines, 1999 (16)
  1985 1999
Category 1 Category 1A
Category II Category 1B
Category III Category II or no recommendation; unresolved
Preoperative hair removal
Do not remove hair unless it will interfere with the operation Recommendation unchanged
Category II Category 1A
If removed, remove by clipping or use of a depilatory, not by If removed, preferably remove immediately before the operation with
shaving electric clippers
Category II Category 1A
Preoperative shower or bath
Patient should bathe with antimicrobial soap the night before Require patients to shower or bathe with an antiseptic agent at least
an elective operation the night before surgery
Category III Category 1B
Preoperative hand and forearm antisepsis
Perform surgical scrub for at least 5 minutes before first Perform surgical scrub for at least 2-5 minutes with an appropriate
operation of day antiseptic
Category 1 Category 1B
Between consecutive operations perform surgical scrub 2 to 5 minutes
Category II
After scrub, dry hands with sterile towel, don sterile gown and After scrub, keep hands up and away from body; dry hands with
gloves sterile towel; don sterile gown and gloves
Category 1 Category 1B
Preoperative patient preparation
Treat and control all bacterial infections before operation Identify and treat all remote infections before elective operation
Category 1 Category 1A
The hospital stay should be as short as possible Keep hospital stay as short as possible
Category II Category II
If patient is malnourished, enteral or parenteral nutrition No recommendation to use nutritional  support solely to prevent
should be given surgical site infection
Category II Unresolved
Preoperative antimicrobial prophylaxis
Use for operations with high infection rate or for those with Administer antimicrobial agent only when indicated and select based
severe or life-threatening consequences if infection occurs on published recommendations for a specific operation and efficacy
Category 1 against most common pathogens
Category 1A
Select antimicrobial agents that are safe and effective
Category 1
Start parenteral IV antimicrobial agents shortly before Administer antimicrobial agents by IV timed to ensure bactericidal
operation and discontinue shortly afterward serum and tissue levels when incision made
Category 1 Category 1A
Maintain therapeutic levels during operation and, at most, a few
hours after closure
Category 1A
Before colorectal elective operations, in addition to IV antimicrobial
drugs, mechanically prepare the colon with enemas and cathartic
agents; administer nonabsorbable oral antimicrobial agents in
individual doses the day before surgery
Category 1A
For cesarean sections in patients at high risk administer IV
antimicrobial agent immediately after cord is clamped
Category 1A
Do not routinely use vancomycin for prophylaxis
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definitive recommendations concerning the proper ap-
proaches to antibiotic prophylaxis in surgery (21).
Current Use of Parenteral Antibiotic
Agents in Surgical Prophylaxis
The choice of parenteral prophylactic antibiotic agents
and the timing and route of administration have become
standardized on the basis of well-planned prospective clinical
studies (21). It is generally recommended in elective clean
surgical procedures using a foreign body and in clean-
contaminated procedures that a single dose of cephalosporin,
such as cefazolin, be administered intravenously by
anesthesia personnel in the operative suite just before
incision. Additional doses are generally recommended only
when the operation lasts longer than 2 to 3 hours. Other
controversial areas include the routine use of antibiotic
prophylaxis in clean surgical procedures, such as hernia
repair or breast surgery (21,22). This subject has been
summarized in a published review (23), and some specific
situations will be described.
Antibiotic Prophylaxis before Elective Colon Resection
The human colon and distal small intestine contain an
enormous reservoir of facultative and anaerobic bacteria,
separated from the rest of the body by the mucous membrane.
A reliable method of sterilizing the colonic contents has been
a goal of surgeons throughout this century (24). In the past 25
years, clinical trials have demonstrated that to substantially
reduce septic complications after elective colon surgery,
antibiotics must have activity against both colonic aerobes
(e.g.,  Escherichia coli) and anaerobes (e.g., Bacteroides
fragilis), a finding we reported over 25 years ago (25). Today,
approaches to mechanical cleansing differ widely (26).
Modern approaches include standard outpatient mechanical
cleansing with dietary restriction, cathartics, and enemas for
a 2-day period, or whole-gut lavage with an electrolyte
solution of 10% mannitol, Fleet’s phospho-soda, or
polyethylene glycol, done the day before the operation.
Most surgeons use both antibiotics and mechanical
cleansing for preoperative preparation before elective colon
resection (26). Three regimens of oral agents combine
neomycin with erythromycin base, metronidazole, or
tetracycline. The most popular regimen in the United States
has been the neomycin-erythromycin base preparation, which
was introduced in 1972 (27).
In a survey published in 1997, 471 (58%) of 808 board-
certified colorectal surgeons described their bowel prepara-
tion practices before elective procedures (26). All respondents
used mechanical preparation: oral polyethylene glycol
solution (70.9% of respondents), oral sodium phosphate
solution with or without bisacodyl (28.4%), and accepted
methods of dietary restriction, cathartics, and enemas
(28.4%). Most (86.5%) surgeons added both oral and
parenteral antibiotics to the regimen; 11.5% added only
parenteral antibiotics, 1.1% added only oral antibiotics, and
0.9% did not add antibiotics. Oral neomycin and erythromycin
or metronidazole were combined with a perioperative
parenteral antibiotic by 77.8% of respondents. Most patients
started the preparation as outpatients the day before surgery,
and parenteral drugs were added to the regimen 1 to 2 hours
before the procedure. The use of outpatient bowel preparation
is increasing; however, patient selection is critical, and
education is needed to reduce the rate of complications.
Antibiotic Prophylaxis for Appendectomy
The pathologic state of the appendix is the most
important determinant of postoperative infection (28,29).
Wound infection after appendectomy for perforative or
gangrenous appendicitis is four to five times higher than for
early disease. A prospective study of nonperforated
appendicitis, using a logistic regression analysis of risk
factors, showed that the risk for postoperative infection is
related to lack of perioperative antibiotic prophylaxis and to
the determination that the appendix was gangrenous (29).
Because the pathologic state of the appendix often cannot be
determined before or during operation, a parenteral antibiotic
agent is recommended as prophylaxis in all patients.
Regimens with activity against both facultative gram-
negative bacilli and anaerobes are more effective than those
active only against aerobes (29). The use of antimicrobial
agents in perforated appendicitis with evidence of local or
general peritonitis or intraabdominal abscess, or both, should
be considered therapeutic rather than prophylactic.
Preventive Antibiotics in Penetrating Abdominal Trauma
Hollow-lumen visceral damage with associated escape of
endogenous microorganisms is the main risk factor for
postoperative infections after exploratory laparotomy for
penetrating abdominal trauma. A single dose of parenterally
administered antibiotic, given just before abdominal
exploration for penetrating abdominal trauma, is associated
with low postoperative infection rate in patients with no
observed gastrointestinal leakage (30). If gastrointestinal
leakage is identified at the time of the operation, continuing
the antibiotic agents for 1 to 3 days is usually recommended.
It is important to use antibiotic agents with both
facultative and anaerobic activity. Leaving the operative
wound open, packed with saline-soaked gauze, decreases
the incidence of postoperative wound infection in patients
at high risk (31).
Preventive Antibiotic Use in Traumatic Chest Injuries
Recently published studies have shown the value of
parenteral antibiotic prophylaxis in the prevention of
pneumonia or empyema after the placement of a chest tube to
correct the hemopneumothorax associated with chest trauma
(32,33). In one study, 500 mg of cefazolin was given
intravenously every 8 hours for 24 hours (32). In the other
study, 1 g of cefonicid was administered every 24 hours until
the chest tube was removed, usually before 5 days (33). In
both studies patients receiving antibiotics had substantially
lower infection rates than those receiving placebos.
Conclusions
Recent improvements in antibiotic prophylaxis, includ-
ing the timing of initial administration, appropriate choice of
antibiotic agents, and shortening the duration of administra-
tion, have established the value of this technique in many
clinical surgical settings. Future study designs should
strongly consider risk factors for individual patients when
new antibiotic agents are tested or administration
techniques are refined. A concentrated effort should be
made in areas of clinical surgery where the value of
antibiotic prophylaxis has not been proven. A single-dose
systemic regimen of an appropriately chosen cephalosporin
given during the immediate preoperative period is safe and
the indicated practice.224 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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